Kernel, a pioneering company at the forefront of precision neuromedicine, has successfully raised an impressive $250 million in its latest funding round. This substantial investment reflects the growing confidence in Kernel's innovative neuroimaging platform, which is designed to revolutionize the way neurological disorders are diagnosed and treated. By providing high-resolution imaging capabilities, Kernel's technology enables researchers and healthcare providers to better understand the complexities of the brain, ultimately facilitating the acceleration of treatment development and significantly improving patient outcomes. The funding will be utilized to enhance Kernel's research and development efforts, allowing the company to refine its platform further and expand its applications within the healthcare industry. Moreover, this influx of capital will contribute to the scaling of production, ensuring that more medical facilities can access this groundbreaking neuroimaging system. With the potential to lower healthcare costs through more efficient treatment protocols and improved diagnostic accuracy, Kernel is not only advancing scientific understanding but also pushing the boundaries of what is possible in patient care. As the company gears up for its next phase of growth, it remains committed to its vision of transforming neuromedicine and making a lasting impact on the lives of patients battling neurological conditions. This funding round marks a significant milestone for Kernel and its mission to harness the power of precision medicine to better serve the healthcare landscape.
Kernel Secures $250 Million in Funding to Revolutionize Precision Neuromedicine
Get the full Kernel company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Garner Health
We believe in transparency, data-driven decision-making, and seamless customer experiences. That’s why we’re building solutions to help employees discover high-quality doctors. Our team includes healthcare operators, clinicians, engineers, and benefits experts, allowing us to develop solutions with a multidisciplinary approach.
$45.0M Series b
today
Signos
Signos is the first FDA-cleared metabolic health platform that helps employees understand and improve their metabolism in real-time, providing employers with the data to make informed benefits decisions. Powered by Dexcom’s Stelo CGM and AI-driven guidance, Signos turns glucose data into personalized, actionable recommendations that support sustainable weight management and better metabolic health. For employers, this means healthier populations, reduced reliance on GLP-1 medications, and more predictable benefit costs through data-driven, predictive health.
$20.0M Series b
today
Third Wave Coffee
Third Wave Coffee is a coffee and food QSR brand founded by Ayush Bathwal, Anirudh Sharma and Sushant Goel in 2015. With a commitment to quality and innovation, the homegrown coffee QSR chain has rapidly expanded to over 140 stores nationwide, earning a reputation as one of the fastest-growing coffee brands in the country. Third Wave Coffee is dedicated to providing a high-quality coffee-first experience to its customers across the country with a specific focus on high-quality beans, convenient locations and a technology-enabled consumer experience. Celebrated as a trailblazer in the industry, the brand was recognised as one of the ET Now Best Brands of 2024. For more information, visit Third Wave Coffee at https://www.thirdwavecoffeeroasters.com.
$80.0M Unknown
today
Enttor
The only outbound software startups need
$410.0K Seed
today
Return Helper
Return Helper provides a unified intelligence platform for cross-border e-commerce, bridging the gap between global sales and local disposal. With deep integration across 20+ strategic hubs in Europe, the Americas, and Asia, we resolve the complexity of international returns for sellers on Amazon, Shopify, and eBay. Our Infrastructure: End-to-End Fulfillment: Precision management for Fashion, Electronics, Furniture, and Baby products. Asset Recovery: We don’t just process returns; we revive them. Through local resale and strategic recycling, we achieve a 70% recovery rate, ensuring inventory stays in the commerce cycle rather than the landfill. Strategic Compliance: Aligning operational excellence with global ESG mandates to future-proof your post-purchase experience.
$4.0M Series a
today